The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 January 2013
|
| In: |
BMC gastroenterology
Year: 2013, Volume: 13 |
| ISSN: | 1471-230X |
| DOI: | 10.1186/1471-230X-13-14 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-230X-13-14 |
| Author Notes: | Jan G. D’Haese, Ihsan Ekin Demir, Timo Kehl, Jannik Winckler, Nathalia A. Giese, Frank Bergmann, Thomas Giese, Markus W. Büchler, Helmut Friess, Mark Hartel and Güralp O. Ceyhan |
| Summary: | The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP). |
|---|---|
| Item Description: | Gesehen am 14.12.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1471-230X |
| DOI: | 10.1186/1471-230X-13-14 |